, and limiting chronic inflammatory diseases, such as asthma and inflammatory bowel disease (IBD) 3, 4 , they also block beneficial responses by preventing sterilizing immunity to certain pathogens 5, 6 and limiting antitumour immunity 7 . A seminal advance in the analysis of T Reg cells came with the identification of a key transcription factor, known as forkhead box P3 (FOXP3), that is required for their development, maintenance and function 8, 9 . Mice (known as scurfy mice, BOX 1) and individuals that lack FOXP3 develop a profound autoimmune-like lymphoproliferative disease that graphically emphasizes the importance of T Reg cells in the maintenance of peripheral tolerance [10] [11] [12] . Although FOXP3 has been proposed to be the master regulator of T Reg cells that controls the expression of multiple genes that mediate their regulatory activity 13, 14 , this notion has recently been challenged, raising the possibility that other transcriptional events may operate upstream of and/or concurrently with FOXP3 to mediate T Reg -cell development 15 . Although FOXP3 has proved to be an invaluable marker of mouse T Reg cells, its role in human T Reg cells is less straightforward (see BOX 2 for a discussion on T Reg -cell markers). Humans that lack functional FOXP3 develop IPEX (immunodysregulation, polyendocrinopathy and enteropathy, X-linked syndrome), which is a severe autoimmune disease that develops early in infancy.
Although FOXP3 appears to be required for human T Regcell development and function, expression of FOXP3 alone is clearly not sufficient for regulatory function, as a significant percentage of human activated T cells express FOXP3 but do not possess regulatory activity [16] [17] [18] [19] [20] . Furthermore, the induction of FOXP3 in human T cells by transforming growth factor-β (TGFβ) does not confer a regulatory phenotype, in contrast to their mouse counterparts 20 . Consequently, FOXP3 is not an adequate marker for human T Reg cells (BOX 2) . Whether this distinction is due to intrinsic differences between mouse and human FOXP3 and/or a requirement for additional cofactors or transcription factors is an important question that needs to be resolved.
Significant progress has been made over the past few years in delineating the molecules and mechanisms that T Reg cells use to mediate suppression 21, 22 . In this Review, we outline our current understanding of the mechanisms used by T Reg cells to mediate suppression, and the challenges that lie ahead in defining their mode of action. We also discuss whether T Reg cells are likely to depend on one, a few or many of these mechanisms. In addition, we propose that effector T cells may have a significant role in boosting and/or modulating T Reg -cell function. Unless otherwise stated, we primarily focus on the mechanisms that are used by thymus-derived, naturally occurring CD4
+ T Reg cells.
Basic mechanisms of T Reg -cell function
Defining the mechanisms of T Reg -cell function is clearly of crucial importance. Not only would this provide insight into the control processes of peripheral tolerance but it would probably also indicate several potentially important therapeutic targets. Although this quest has been ongoing
Peripheral tolerance
The lack of self-responsiveness of mature lymphocytes in the periphery to specific antigens. These mechanisms control potentially self-reactive lymphocytes that have escaped central-tolerance mechanisms. Peripheral tolerance is associated with suppression of the production of self-reactive antibodies by B cells and inhibition of selfreactive effector T cells, such as cytotoxic T lymphocytes. The actions of regulatory T cells constitute one mechanism of peripheral tolerance.
Type 1 diabetes
A chronic autoimmune disease that is characterized by the T-cell-mediated destruction of β-cells (which secrete insulin) in the pancreas. Individuals with type 1 diabetes develop hyperglycaemia and can develop diabetes-associated complications in multiple organ systems owing to a lack of insulin.
Inflammatory bowel disease
(IBD). A T-cell-mediated inflammatory response that affects the gastrointestinal tract. There are two forms of IBD in humans; Crohn's disease, which can affect any part of the gastrointestinal tract but usually descends from the terminal ileum, and ulcerative colitis, which mainly affects the colon. In the mouse model of IBD, most of the inflammation is confined to the large intestine. The target antigen for the pathogenic T cells is unknown.
Sterilizing immunity
An immune response that leads to the complete removal of the pathogen.
since interest in T Reg cells was re-ignited in 1995 (REF. 23 ), there has been significant progress in the past few years. From a functional perspective, the various potential suppression mechanisms used by T Reg cells can be grouped into four basic 'modes of action': suppression by inhibitory cytokines, suppression by cytolysis, suppression by metabolic disruption and suppression by modulation of dendritic-cell (DC) maturation or function (FIG. 1) .
Suppression by inhibitory cytokines. Inhibitory cytokines, such as interleukin-10 (Il-10) and TGFβ, have been the focus of considerable attention as mediators of T Reg -cellinduced suppression. There has also been significant interest in their ability to stimulate the development of induced (also known as adaptive) T Reg -cell populations, either in vivo or experimentally as a potential therapeutic modality
. Although the general importance of Il-10 and TGFβ as suppressive mediators is undisputed, their contribution to the function of thymus-derived, naturally occurring T Reg cells is still a matter of debate 24 . This is partly due to the general perception that T Reg cells function in a contact-dependent manner 25, 26 . Indeed, in vitro studies using neutralizing antibodies or T cells that are unable to produce or respond to Il-10 and TGFβ suggested that these cytokines may not be essential for T Reg -cell function [25] [26] [27] [28] . However, this is in contrast with data from in vivo studies 29, 30 . In allergy and asthma models, evidence suggests that both naturally occurring and induced antigen-specific T Reg cells control disease in a manner that is, in part, dependent on Il-10 (REF. 29 ) and in some reports dependent on both Il-10 and TGFβ (REF. 31 ). Following allergen challenge, CD4
+ effector T cells were stimulated to produce considerable amounts of Il-10 in the lung by allergenspecific T Reg cells that had been adoptively transferred, and thereby were able to control disease; this effect could be reversed with the administration of an antibody specific for the Il-10 receptor 32 . However, following the transfer of Il-10-deficient T Reg cells, allergic inflammation and airway hyper-reactivity were still suppressed and the production of Il-10 was also increased, which suggests that the suppression of the T helper 2 (T H 2)-driven response to allergens in vivo by T Reg cells is dependent on Il-10, but that the production of Il-10 by T Reg cells themselves is not required for the suppression observed. This contrasts with a recent study suggesting that the T Reg -cell-specific ablation of Il-10 expression resulted in increased lung allergic inflammation and hyper-reactivity 33 . This scenario might also occur in other disease models. For instance, the effects of Il-10 on the immune response to hepatitis B virus 34 and on the allograft tolerance response elicited by splenocytes exposed to non-inherited maternal antigens can only be partially attributed to T Reg -cell-derived Il-10 (REF. 35 ). Recently, it was also shown that Il-10 is crucial for the control of Box 1 | Scurfy mice: misplaced mechanistic expectations?
Mice that carry a spontaneous loss-of-function mutation (known as scurfy mice) or a deletion of forkhead box P3 (Foxp3) develop a fatal autoimmune-like disease with hyper-responsive CD4 + T cells 9, 12 . More recently, the generation of Foxp3-diphtheriatoxin-receptor (DTR) knock-in mice has allowed for the selective depletion of regulatory T (T Reg ) cells following treatment with diphtheria toxin 105 . These mice have been invaluable for dissecting the role of FOXP3 in T Reg -cell function.
Given the profound phenotype of these mice, there is a general expectation that genetic disruption of any key T Reg -cell inhibitory-dependent molecule or suppression mechanism would probably result in a scurfy-like phenotype. Of course, it is also possible that deletion of a key T Reg -cell gene may be more synonymous with diphtheria-toxin-mediated T Reg -cell depletion in which FOXP3 might still prevent expression of pro-inflammatory cytokines 105 . Nonetheless, this has led to the notion that if mutant mice don't have a scurfy-like or a T Reg -cell-depleted phenotype, then the disrupted gene probably isn't important for T Reg -cell function. However, this may not necessarily be correct. Indeed, it is possible that no mouse lacking a T Reg -cell inhibitory molecule will ever be generated that develops a profound, spontaneous autoimmune disease 21 . It should be noted that mutant mice that are colonized by Helicobacter spp. and/or Citrobacter rodentium may have an exacerbated phenotype, as several studies have shown that opportunistic enteric bacteria can significantly exacerbate gut pathology 4 . Ultimately, the occurrence of disease in mice lacking a T Reg -cell inhibitory molecule will depend on whether T Reg cells rely on single or multiple suppressive mechanisms. Given the number of genes induced or modulated by FOXP3, it is probable that a programme of intrinsic and extrinsic regulation is induced that involves multiple proteins 9, 13 . Therefore, it would not be surprising if deletion of a single molecule does not provoke the profound scurfy-like phenotype seen in mice that lack FOXP3. 
CD45RB
low expression. However, the purity of isolated human T Reg cells has always been an issue because T cells upregulate CD25 expression upon activation 106 . Indeed, during the influenza or allergy season, a substantial proportion of human CD4 + T cells can express CD25. Although the identification of forkhead box P3 (FOXP3) as a key regulator of T Reg -cell development and function has facilitated their identification in mice 8 , many activated (non-regulatory) human T cells also express FOXP3, precluding it as a useful marker for human T Reg cells [16] [17] [18] [19] [20] . Consequently, the search for T Reg -cell-specific cell-surface markers, particularly in humans, has continued in earnest with a growing number of candidates proposed (reviewed in REF. 107 ). For instance, it was shown that the expression of CD127 (also known as IL-7R) is downregulated by T Reg cells, and that this could be used to increase the purity of human T Reg -cell isolation. Indeed, there is a 90% correlation between CD4
low T cells and FOXP3 expression 108, 109 . In addition, it was recently found that T Reg cells expressed a higher level of folate receptor 4 compared with activated effector T cells 110 . It is also important to recognize that T Reg cells, like their T-helper-cell counterparts, may be heterogeneous and thus a collection of cell-surface markers could facilitate their isolation and functional characterization. Indeed, such heterogeneity has recently been described based on differential expression of HLA-DR or CC-chemokine receptor 6 (CCR6) 102, 103 . However, the general use of both markers remains to be fully established. Therefore, it is quite probable that the search for better T Reg -cell markers will continue for some time. 
Membranetethered TGFβ

Airway hyper-reactivity
Initiated by exposure to a defined stimulus that is usually tolerated by normal individuals and that causes bronchoconstriction and airway infiltration of inflammatory cells in allergic individuals. 38 and Trichinella spiralis 39 . However, T Reg cells were not the source of Il-10 in these infection models.
Experimental autoimmune encephalomyelitis (EAE
In contrast to the previous studies, Il-10 production by T Reg cells has been shown to be essential for the prevention of colitis in mouse models of IBD 40 . Moreover, it appears that the tumour microenvironment promotes the generation of FOXP3 + T Reg cells that mediate Il-10-dependent, cell-contact independent suppression 41 . Similarly, in Uv-radiation-induced carcinogenesis, Il-10 production by T Reg cells appears to be important for blocking antitumour immunity 42 . Il-10 produced by T Reg cells also appears to be important for Il-10-mediated tolerance in a model of hepatitis induced by concanavalin A 43 and for tolerance to bacterial and viral superantigens 44 . In addition, recently published papers suggest new roles for T Reg -cell-derived Il-10 in the induction of feto-maternal tolerance 45 and B-cell-enhanced recovery from experimental autoimmune encephalomyelitis (EAE) 46 . Interestingly, the T Reg -cell-specific deletion of Il-10 did not result in the development of spontaneous systemic autoimmunity, but did result in enhanced pathology in the colon of older mice and in the lungs of mice with induced airway hypersensitivity, suggesting that the function of T Reg -cell-derived Il-10 may be restricted to the control of inflammatory responses that are induced by pathogens or environmental insults 33 . Collectively, the picture that appears to be emerging is that the relative importance of Il-10 production by T Reg cells as a mechanism of T Reg -cellmediated suppression is dependent on the target organism or disease and on the experimental system. Although some early in vitro studies using neutralizing antibodies specific for TGFβ or using T Reg cells that lack TGFβ (REFs 25,47) indicated that TGFβ was not required for the function of naturally occurring T Regcells, other studies, both in vitro and in vivo, suggested a crucial role for T Reg -cell membrane-tethered TGFβ (REFs 48, 49) . Therefore, the importance of TGFβ for naturally occurring T Reg -cell function has also been a controversial topic. Indeed, there has been considerably more focus recently on the importance of TGFβ in the development of induced T Reg cells and perhaps in T Regcell maintenance in general 
Notch
A transmembrane receptor involved in the pathway for direct cell-cell signalling that regulates cell-fate choice in the development of many cell lineages, and therefore is vital in the regulation of embryonic differentiation and development.
T Reg cells has been found to be important in the control of the host immune response to M. tuberculosis 36 , suppression of allergic responses 31 and prevention of colitis in an IBD model 51 . Interestingly, TGFβ produced by T Reg cells has also been implicated in limiting antitumour immunity in head and neck squamous-cell carcinoma 52 and in follicular lymphoma 53 , by rendering T cells unresponsive to the tumour. TGFβ also appears to limit the antitumour activity of cytokine-induced killer cells 54 . Membrane-tethered TGFβ can also mediate suppression by T Reg cells in a cell-cell contact-dependent manner 48 . T Reg cells can control the infiltration of CD8 + T cells to pancreatic islets and delay the progress of diabetes through membrane-tethered TGFβ (REF. 49 ). However, experiments using mice in which the effector T cells were deficient in TGFβ-receptor (TGFβR) signalling or using TGFβ or TGFβR blocking reagents failed to show that membrane-tethered TGFβ is required for naturally occurring T Reg -cell development or function 47 . More recently, however, interest in membrane-tethered TGFβ has re-surfaced with the description of a previously unappreciated role for it in the tumour microenvironment. TGFβ that is associated with tumour exosome membranes appears to enhance the suppressive function of T Reg cells and skew T cells away from their effector functions and towards regulatory functions 55 . Furthermore, ovalbumin-induced airway inflammation can be attenuated by haeme oxygenase-1 through membrane-tethered TGFβ and Il-10 secretion by T Reg cells 56 , a process that activates the Notch1-HES1 (hairy and enhancer of split 1) axis in target cells 57 . Therefore, in light of the most current data, it now appears that soluble and/or membranetethered TGFβ may have a previously unappreciated role in the function of naturally occurring T Reg cells.
Recently, a new inhibitory cytokine, Il-35, has been described that is preferentially expressed by T Reg cells and is required for their maximal suppressive activity 58 . Il-35 is a new member of the Il-12 heterodimeric cytokine family and is formed by the pairing of Epstein-Barr virus-induced gene 3 (Ebi3; which normally pairs with p28 to form Il-27), and p35 (also known as Il12a; which normally pairs with p40 to form Il-12). Both Ebi3 and Il12a are preferentially expressed by mouse FOXP3 + T Reg cells 58, 59 , but not resting or activated effector T cells, and are significantly upregulated in T Reg cells that are actively suppressing 58 . As predicted for a heterodimeric cytokine, both Ebi3 -/-and Il12a -/-T Reg cells had significantly reduced regulatory activity in vitro and failed to control homeostatic proliferation of effector T cells and resolve IBD in vivo. This precise phenotype suggested that Il-35 is required for the maximal suppressive activity of T Reg cells. Importantly, Il-35 was sufficient for T Reg -cell activity, as ectopic expression of Il-35 conferred regulatory activity on naive T cells and recombinant Il-35 suppressed T-cell proliferation in vitro 58 . Although Il-35 is an exciting addition to the T Reg -cell portfolio, there is clearly much that remains to be defined about this cytokine and its contribution to T Reg -cell function. For instance, it remains to be determined whether Il-35 suppresses the development and/or function of other cell types, such as DCs and macrophages.
It is now clear that three inhibitory cytokines, Il-10, Il-35 and TGFβ, are key mediators of T Reg -cell function. Although they are all inhibitory, the extent to which they are used in distinct pathogenic and/or homeostatic settings differs, suggesting a non-overlapping function, but this hypothesis needs further refinement. + regulatory T (T Reg ) cells develop in the thymus and display a diverse T-cell receptor (TCR) repertoire that is specific for self antigens 111, 112 . However, T Reg cells can also be 'induced', 'adapted' or 'converted' from effector T cells during inflammatory processes in peripheral tissues, or experimentally generated for therapeutic purposes 29, 113, 114 . For instance, T regulatory 1 (T R 1) cells and T helper 3 (T H 3) cells can be generated experimentally by and mediate their suppressive activity through interleukin-10 (IL-10) and transforming growth factor-β (TGFβ), respectively 114, 115 . Typically, these regulatory populations do not express FOXP3.
In vivo, it has recently been suggested that stimulation of mouse effector T cells by CD103 + dendritic cells (DCs) in the presence of TGFβ and retinoic acid induces the generation of FOXP3 + T cells in the gut-associated lymphoid tissue (GALT) [116] [117] [118] [119] [120] [121] . Furthermore, T Reg cells can be preferentially induced in the periphery by exposure to α V β 8 -integrinexpressing DCs 122 or DCs deficient in suppressor of cytokine signalling 3 (SOCS3) (REF. 123 ). Interestingly, independent of its role in generating induced T Reg cells, TGFβ may also have an important role in helping to maintain FOXP3 expression by thymus-derived, naturally occurring T Reg cells 124 , a process that can be blocked by IL-4 or interferon-γ (REF. 125 ).
In contrast to mouse T cells, FOXP3 induction by TCR stimulation in the presence of TGFβ in human T cells does not confer a regulatory phenotype 20 . The mechanism of action of induced T Reg cells may not necessarily be restricted to suppressive cytokines. Indeed, human induced T Reg cells (CD4 + CD45RA + T cells stimulated with CD3-and CD46-specific antibodies) have also been shown to express granzyme B and killing target cells in a perforindependent manner 126 . In contrast to naturally occurring T Reg cells, induced T Reg cells often have a restricted specificity for particular cell types, tumours or foreign antigens 127 . Therefore, induced T Reg cells may be ideally suited to respond to infectious agents. This may also be of particular importance in the GALT and in the tumour microenvironment where TGFβ drives the conversion of induced T Reg cells 118, 128 . A significant challenge in deciphering data from in vivo experiments is to assess the contribution of naturally occurring T Reg cells versus induced T Reg cells, and to determine whether inhibitory molecules, such as IL-10 or TGFβ, are derived from the former or the latter (or by other cells). 
Ectoenzymes
Enzymes that are outside the cell membrane and therefore can cleave extracellular substrates. These are typically tethered to the outside of the cell by a transmembrane domain.
T H 17 cells (T helper 17 cells). A subset of CD4 + T helper cells that produce interleukin-17 (IL-17)
and that are thought to be important in inflammatory and autoimmune diseases. Their generation involves IL-6, IL-21 and IL-23, as well as the transcription factors RORγt (retinoic-acid-receptor-related orphan receptor-γt) and sTAT3 (signal transducer and activator of transcription 3).
Intravital microscopy
This is used for examination of biological processes, such as leukocyte-endothelial-cell interactions, in living tissue. In general, translucent tissues are used, such as the mesentery or cremaster muscle, which can be exposed and mounted for microscopic observation. By contrast, as mouse CD4 + T cells are not cytolytic, it was surprising that early gene expression arrays showed that the expression of granzymeB was upregulated in mouse T Reg cells 62, 63 . Noelle and co-workers were the first to report that granzyme-B-deficient mouse T Reg cells had reduced suppressive activity in vitro, and that this granzyme-B-dependent suppression appeared to be a perforin-independent result of T Reg -cell-induced apoptosis of effector T cells 64 . The notion that T Reg cells might possess cytolytic activity was supported by studies showing that T Reg cells can kill B cells in a granzyme-Bdependent and partially perforin-dependent manner that results in the suppression of B-cell function 65 . More recently, T Reg cells were shown to suppress the ability of NK cells and CTls to clear tumours by killing these cells in a granzyme-B-dependent and perforin-dependent manner 66 . In addition, effector T cells that overexpress the granzyme-B-specific inhibitor SPI6 are resistant to T Reg -cell-mediated suppression (R. Noelle, personal communication). Using a transplantation model in which T Reg -cell-mediated tolerance is induced by CD40-CD154 co-stimulatory blockade in conjunction with donor lymphocyte-specific transfusion, Noelle and colleagues have also shown that the T Reg cells that mediate this tolerance also depended on granzyme B for their suppressive activity.
Suppression by cytolysis.
Although the majority of research to date regarding T Reg -cell-induced cytolysis has focused on granzyme-Bmediated mechanisms, a recent study has suggested that activated T Reg cells induce apoptosis of effector T cells through a TRAIl-DR5 (tumour-necrosis-factor-related apoptosis-inducing ligand-death receptor 5) pathway 67 . Furthermore, galectin-1 (also known as lGAlS1), which can induce T-cell apoptosis, has been shown to be upregulated by mouse and human T Reg cells and galectin-1-deficient T Reg cells have reduced regulatory activity in vitro 68 . These studies emphasize that more work is required to define the cytolytic mechanisms that T Reg cells use to mediate suppression.
Suppression by metabolic disruption. Recently, several intriguing suppressive mechanisms have been described that could collectively be referred to as mechanisms that mediate 'metabolic disruption' of the effector T-cell target. A long-standing debate in the T Reg -cell field is whether the high expression level of CD25 empowers T Reg cells to 'consume' local Il-2 and therefore starve actively dividing effector T cells by depleting the Il-2 they need to survive 26, 69 . Although previous studies suggested that this was not a bona fide T Reg -cell mechanism 70, 71 , a recent study has re-ignited interest in this question by suggesting that T Reg cells induce cytokine (specifically Il-2)-deprivationmediated apoptosis 72 . However, given that a recent report using human T Reg cells suggested that Il-2 depletion alone is not required for T Reg cells to suppress effector T cells 73 , more work is clearly necessary to resolve this debate.
Two new T Reg -cell mechanisms have recently been proposed that induce the intracellular or extracellular release of adenosine nucleosides. Concordant expression of the ectoenzymes CD39 and CD73 was shown to generate pericellular adenosine, which suppressed effector T-cell function through activation of the adenosine receptor 2A (A 2A R) [74] [75] [76] . Interestingly, binding of adenosine to A 2A R appears to not only inhibit effector T-cell functions, but also to enhance the generation of induced T Reg cells by inhibiting Il-6 expression while promoting TGFβ secretion 77 . In addition, adenosine has also been shown to modulate DC maturation and favour a tolerogenic phenotype (P. Ernst, personal communication). Although TGFβ induces FOXP3 expression and T Reg -cell differentiation, Il-6 inhibits the generation of T Reg cells and promotes the generation of pro-inflammatory T H 17-cell development 78 . Therefore, inhibiting Il-6 has important implications in the maintenance of T Reg cells. T Reg cells were also shown to suppress effector T-cell function directly by transferring the potent inhibitory second messenger cyclic AMP (cAMP) into effector T cells through membrane gap junctions 79 . Although these mechanisms represent interesting additions to the list of potential mechanisms used by T Reg cells to mediate suppression, further studies will be required to corroborate these exciting findings and assess the relative use of these mechanisms by T Reg cells.
Suppression by targeting dendritic cells.
In addition to the direct effect of T Reg cells on T-cell function, T Reg cells might also modulate the maturation and/or function of DCs, which are required for the activation of effector T cells. Although this is an attractive idea, the data in support of this theory are limited 80 . Interestingly, studies using intravital microscopy have revealed direct interactions between T Reg cells and DCs in vivo. These interactions were proposed to function in attenuating effector T-cell activation by DCs 81, 82 in a process involving the co-stimulatory molecule cytotoxic T-lymphocyte antigen 4 (CTlA4), which is constitutively expressed by T Reg cells 25, 83 . More specifically, the use of CTlA4-specific blocking antibodies or CTlA4-deficient T Reg cells showed that in the absence of functional CTlA4, T Reg -cell-mediated suppression of effector T cells via DCs was reduced 84, 85 . Importantly, it was also shown that T Reg cells could condition DCs to express indoleamine 2,3-dioxygenase (IDO), a potent regulatory molecule which is known to induce the production of pro-apoptotic metabolites from the catabolism of tryptophan, resulting in the suppression of effector T cells through a mechanism dependent on interactions between CTlA4 and CD80 and/or CD86 (REFs 86, 87) .
In addition to inducing DCs to produce immunosuppressive molecules, several studies have suggested that T Reg cells may also downmodulate the capacity of DCs to activate effector T cells. Ivars and colleagues first reported that T Reg cells could downregulate the expression of the co-stimulatory molecules CD80 and CD86 by DCs in vitro 88 . Several studies have also reported the immunomodulatory effects of T Reg cells on DC maturation and/or function 85, [89] [90] [91] [92] . Studies with human T Reg cells have also indicated that T Reg cells may modulate the function of monocytes and macrophages 93, 94 . Although the precise mechanism by which this is orchestrated is not known, this modulation may be mediated through cell-surface molecules such as CTlA4 and/or cytokines such Il-10 and TGFβ.
Recent studies have also suggested that lymphocyteactivation gene 3 (lAG3; also known as CD223) may block DC maturation. lAG3 is a CD4 homologue that binds MHC class II molecules with very high affinity, has a negative regulatory T-cell intrinsic function and is required for maximal T Reg -cell suppression 95, 96 . Binding of lAG3 to MHC class II molecules expressed by immature DCs induces an immunoreceptor tyrosine-based activation motif (ITAM)-mediated inhibitory signalling pathway -which involves FcγRγ and extracellularsignal-regulated kinase (ERK)-mediated recruitment of SRC-homology-2-domain-containing protein tyrosine phosphatase 1 (SHP1) -that suppresses DC maturation and their immunostimulatory capacity 97 . It is noteworthy that human MHC class II + T Reg cells have been shown to be more suppressive than MHC class II -T Reg cells, raising the possibility that these cells suppress by ligating lAG3 on activated effector T cells 98 . Although more work is required to fully elucidate if and how T Reg cells might suppress effector T-cell function through DCs, this mode of action is an attractive possibility, as it may be a more efficient way of suppressing immune responses in vivo given the ∼1:8 ratio of T Reg cells to effector T cells, compared with the ∼1:0.8 T Reg -cell to DC ratio found in the peripheral lymph nodes (as determined by flow cytometry and cell counting of pooled lymph nodes; C.j.W. and D.A.A.v., unpublished observations). Furthermore, it has recently been shown that neuropilin-1 promotes prolonged interactions with T Reg cells and immature DCs 99 . Given that neuropilin-1 is differentially expressed by T Reg cells, this may give them an advantage over naive T cells in modulating the function of DCs.
Finally, T Reg cells can also influence immune responses by modulating the recruitment and function of other cell types. For instance, T Reg -cell-derived Il-9 has been shown to recruit and activate mast cells, which were shown to be essential regulatory intermediaries in the establishment of peripheral allograft tolerance 100 .
Complicating issues. It is the current opinion that a hallmark of T Reg cells is their dependence on direct cell-cell contact to mediate their inhibitory activity. This has been supported by in vitro experiments showing that T Reg cells could not suppress effector T-cell proliferation when the two populations were separated by a permeable membrane 25, 26 . However, there are two important issues one should consider when evaluating the T Reg -cell mechanisms outlined above in the context of contact dependency. First, these assays are really a measure of proximity rather than contact. Indeed, soluble mediators are most effective close to the source of their generation. The close proximity maintains high local cytokine concentrations, which has been shown to be important for the function of Il-2 (REF. 101 ). Therefore, the dilution effect of diffusion across the permeable membrane might render a soluble mediator ineffective. One should also consider the importance of proximity for labile mediators that might be very effective when T Reg cells are close to their target cells but not when far apart. One example of a labile mediator is adenosine, which has a half life of less than 10 seconds.
Second, it is not yet clear how much of the regulatory potency of T Reg cells is directed towards DCs or other antigen-presenting cells (APCs) versus effector T cells. Although several studies have shown that T Reg cells can directly suppress effector T cells in vitro in the absence of APCs, there is no direct evidence that contact between T Reg cells and effector T cells is required for suppression in vivo. Indeed, intravital microscopy experiments suggest that T Reg cells are far more frequently found in contact with DCs 81,82 compared with effector T cells. Furthermore, it is still not clear what the primary target is for many of the mechanisms described above. For instance, suppression by cytolysis, adenosine or cAMP could be directed against DCs and/or effector T cells. Inhibitory cytokines could also influence both populations. For example, although Il-35 was shown to directly act on effector T cells, an effect on DCs has not been precluded. The one mechanism that might be considered to be effector-T-cell exclusive is Il-2-deprivation-mediated apoptosis. Clearly, more work is needed to determine the primary target of T Reg -cell suppression, particularly in vivo.
How many mechanisms do T Reg cells need?
Although efforts to define the suppressive mechanisms used by T Reg cells continue, an important question looms large. Is it likely that all these molecules and mechanisms will be crucial for T Reg -cell function? There are three broad possibilities.
The first possibility is that a single, overriding suppressive mechanism is used by all T Reg cells. Until the entire mechanistic panoply of T Reg cells is defined, one cannot completely rule this possibility out. However, this would seem unlikely as none of the molecules and/or mechanisms that have been defined to date result in the complete absence of regulatory activity when blocked or deleted -a consequence that one might predict would result in a 'scurfy-like' phenotype
. So, although T Reg cells that lack a single molecule, for instance Il-10, Il-35 or granzyme B, exhibit a significantly reduced suppressor function, a scurfy-like phenotype does not ensue. Given that none of the current T Reg -cell mechanisms can exclusively claim this distinction, it seems unlikely that any 'unknown' molecules or mechanisms could do so either.
The second possibility is that multiple, non-redundant mechanisms are required for maximal T Reg -cell function. In the studies conducted to date, T Reg cells that lack various suppressive molecules have been shown to be functionally defective. This favours a scenario in which there are multiple non-redundant mechanisms that can be used by T Reg cells, with each molecule contributing to the mechanistic whole. At present, this possibility would seem plausible. Indeed, this is supported by the recent analysis of mice possessing a T Reg -cell-specific ablation of Il-10 expression, in which enhanced pathology was observed following environmental insult 33 . One would predict that at some point we should be able to generate knockout mice that lack a particular set of genes, and have a complete loss of T Reg -cell activity. For this to be truly non-redundant, the list of genes would probably be restricted (2-4 genes) .
The third possibility is that multiple, redundant mechanisms are required for maximal T Reg -cell function. With the plethora of regulatory mechanisms described to date and the possibility of more yet to be identified, it is conceivable that there are multiple mechanisms that function redundantly. Such a redundant system would help to mitigate against effector-T-cell escape from regulatory control. Also, given the very small size of the T Reg -cell population, a sizeable arsenal may be required at the height of an effector T-cell attack to control the response. Of course, it is possible that a semi-redundant scenario exists.
These possibilities have been discussed from the perspective of there being a single homogeneous T Reg -cell population. However, similar to helper-T-cell subsets, it remains possible that a few or even many different T Reg -cell subsets exist 24 . Each of these may rely on one or multiple regulatory mechanisms. Several recent studies have provided support for both phenotypic and functional heterogeneity among T Reg cells. For instance, it has recently been shown that a small subpopulation of T Reg cells expresses CC-chemokine receptor 6 (CCR6), which is associated with T cells that possess an effector-memory phenotype 102 . CCR6 + T Reg cells appeared to accumulate in the central nervous system of mice with EAE, suggesting that they may have a prevalent role in controlling responses in inflamed tissues. Heterogeneous expression of HlA-DR has also been suggested to mark different subpopulations of functionally distinct human T Reg cells 103 . Indeed, HlA-DR + T Reg cells were found to be more suppressive than their HlA-DR -counterparts. One might speculate that their enhanced inhibitory activity is due to HlA-DR-mediated ligation of the inhibitory molecule lAG3 expressed by activated effector T cells 95, 96 . So, if multiple suppressor mechanisms exist, how might these be integrated and used productively by T Reg cells in vivo? We would propose the following possible models 21 . First, a 'hierarchical' model in which T Reg cells have several suppression mechanisms that could be used but only one or two of these are really crucial and consistently important in various regulatory settings. Second, a 'contextual' model in which the background or context in which the T Reg cells reside and the type of target cell that they have to repress dictate the appropriate suppression mechanism(s) that is used. For example, in some cases, cell types may be primarily inhibited by cytokines, whereas other cell types may be most effectively suppressed by T Reg -cell-mediated lysis. Alternatively, different mechanisms may be more effective in different tissue compartments or in different disease settings. This notion is supported by the recent analysis of mice in which Il-10 expression was specifically ablated in T Reg cells 33 . Whereas T Regcell-derived Il-10 was not required for the systemic control of autoimmunity, it did seem to be required for the control of inflammatory events at mucosal interfaces, such as the lungs and colon. As a clear picture of the available T Reg -cell suppressor arsenal emerges, an important challenge will be to determine their relative importance and contribution to T Reg -cell function in different disease models.
Do effector T cells potentiate T Reg -cell function?
Most cellular interactions in the immune system are bidirectional, with molecular signals moving in both directions even though the interaction has broader unidirectional intentions (for example, CD4 + T-cell help). However, the general perception to date is that T Reg cells suppress and effector T cells capitulate. We speculate that this is in fact an incomplete picture and that effector T cells have a very active role in their own functional demise. Three recent observations support this view. First, we have recently examined the molecular signature of activated T Reg cells in the presence or absence of effector T cells and were surprised to find that it was strikingly different, with hundreds of genes differentially modulated as a consequence of the presence of effector T cells (C.j.W. and D.A.A.v., unpublished observations). Second, we have shown that Ebi3 and Il12a mRNA are markedly upregulated in T Reg cells that were cultured with effector T cells, supporting the idea that effector T cells may provide signals that boost Il-35 production in trans 58 . Third, we found that T Reg cells were able to mediate suppression of effector T cells across a permeable membrane when placed in direct contact with effector T cells in the upper chamber of a transwell plate (l.W.C. and D.A.A.v., unpublished observations). Interestingly, this suppression was Il-35 dependent, as Ebi3 -/-T Reg cells were unable to mediate this 'long-distance' suppression. Collectively, these data suggest that it is the 'induction' , rather than the 'function' , of T Reg -cell suppression that is contact-dependent and that effector T cells have an active role in potentiating T Reg -cellmediated suppression. Therefore, we propose that receptor-ligand interactions between the co-cultured CD4 + effector T cells and T Reg cells initiate a signalling pathway that leads to enhanced Il-35 secretion and regulatory activity (FIG. 2) . Although the molecule that mediates this enhanced T Reg -cell suppression is unknown, it is possible that Il-2 may serve this function 104 . Given the contrasting genetic profiles of activated T Reg cells in the presence and absence of effector T cells, it seems possible that this interaction may boost the expression of other regulatory proteins. It may well be that effector T cells unwittingly perform the ultimate act of altruism. Although it seems unlikely that all or many of these will be important for T Reg -cell function, it is quite possible that a few undiscovered genes might be important. It should be noted that although we are discussing mechanisms here, it is clear that some of these molecules may be essential in T Reg -cell homing, homeostasis and other key functions, which might indirectly influence T Reg -cell-mediated suppression in vivo without directly contributing to their inhibitory activity. It is also possible that some of these unknown molecules may represent more specific markers for the characterization and isolation of T Reg cells, a particularly important issue for the analysis and use of human T Reg cells
.
Second, which mechanisms are most important? A significant but potentially complex challenge will be to determine if a few mechanisms are important in many T Reg -cell settings or whether different mechanisms are required in different cellular scenarios. At present, it is difficult to assess this objectively as these mechanisms have predominantly been elucidated in different laboratories using distinct experimental systems and thus have not really been compared in side-by-side experiments. Furthermore, conditional mutant mice with a regulatory component specifically deleted in T Reg cells 33 have only recently been examined.
It almost goes without saying that although defining the T Reg -cell mode of action is of great academic importance, it is also essential to develop effective approaches for the clinical manipulation of T Reg cells. Given the capacity of T Reg cells to control inflammation and autoimmunity, and their role in blocking effective antitumour immunity and preventing sterilizing immunity, it seems probable that a clear understanding of how T Reg cells work will present definitive opportunities for therapeutic intervention. 
